Cancer Treatment Centers of America

July 2013 - Genomic Tumor Assessment

  Issue #80, July 2013      
  Follow Us On  
Article Image
Genomic tumor assessment at CTCA

Cancer Treatment Centers of America® (CTCA) now offers expanded genomic tumor assessment that may identify cancer treatment options not previously considered.

Genomic tumor assessment reveals the DNA alterations that are driving the growth of a cancer. As we understand more about these gene mutations, we are better able to provide cancer treatment therapies that specifically target changes in the tumor's genomic profile.

Article Image
The promise of precision cancer treatment

Precision cancer treatment looks at a patient's tumor on a genetic level to find what's driving the cancer's growth. By identifying DNA mutations in a cancer cell, our physicians can better understand what caused the tumor and tailor a patient's treatment based on these findings. Learn more from our infographic.

Cancer in the News

Learn more about genomic tumor assessment by watching this video.

Did You Know
  • Traditionally, cancer has been defined by where it occurs in the body.
  • In recent years, researchers have found that a particular cancer in one patient doesn't necessarily behave the same way in another patient.
  • Cancers now are being categorized by the underlying gene mutations that drive the cancer's growth.

Cancer Treatment Centers of America (CTCA), a national network of fully-accredited cancer hospitals, offers some of the most advanced treatments and technologies for fighting cancer. CTCA doctors have expertise in treating most types of cancer, while specializing in complex and advanced cases. They work as a team, alongside cancer experts from multiple disciplines, to keep patients strong in body, mind and spirit. Visit the full website to learn more, or contact us at 1-800-234-0509. If you no longer wish to receive the Cancer Center Newsletter, click here to unsubscribe.

© 2017 Rising Tide